Rivaroxaban Dosing and Management in Elderly Patients with Atrial Fibrillation and DVT

Dosing Recommendations

For patients with atrial fibrillation and normal or mild renal impairment (CrCl ≥50 mL/min), the American Heart Association recommends a standard dose of rivaroxaban of 20 mg once daily 1
For patients with moderate renal impairment (CrCl 15-50 mL/min), the American College of Cardiology recommends reducing the dose to 15 mg once daily 1, 2
In elderly patients (≥80 years), the European Society of Cardiology suggests that renal function is likely to be compromised, necessitating dose adjustment even without laboratory confirmation of renal impairment 3
At 89 years of age, this patient falls into a high-risk category where careful dosing is critical to prevent bleeding complications, according to the European Heart Journal 4

The American Society of Anesthesiologists recommends obtaining baseline renal function via creatinine clearance (CrCl) calculation using the Cockcroft-Gault formula 5
The European Heart Journal suggests assessing bleeding risk factors, particularly given the patient's advanced age 4
The International Society on Thrombosis and Haemostasis recommends checking for potential drug interactions, especially P-glycoprotein inhibitors or CYP3A4 inhibitors which may increase rivaroxaban exposure 3
Renal function should be assessed at baseline and monitored periodically during treatment, according to the American College of Cardiology 1

Gastrointestinal bleeding risk is approximately 50% higher with rivaroxaban compared to warfarin in elderly patients, requiring vigilance, as reported in Circulation 6
The European Heart Journal recommends avoiding concomitant use with strong inhibitors of both CYP3A4 and P-glycoprotein (e.g., ketoconazole, itraconazole) 3
The American College of Cardiology suggests using caution with other antiplatelet agents or NSAIDs due to increased bleeding risk 4

For procedures with high bleeding risk, the European Society of Anaesthesiology recommends discontinuing rivaroxaban 5 days prior to the procedure in elderly patients 5
For procedures with moderate bleeding risk, discontinuation timing depends on renal function and age, according to the European Society of Anaesthesiology 5